Language: BG BG
← Back to results
Active (not recruiting) Not applicable NCT07341633

AI-Based Digital Therapeutics vs. Traditional Schroth Exercises for Adolescent Idiopathic Scoliosis

No applicable phase (e.g. observational)
Conditions: Adolescent Idiopathic Scoliosis (AIS)

Sponsor: Jinan University Guangzhou

trial.available_in: БГ
Overview
This randomized controlled trial (RCT) evaluates the efficacy of a novel Artificial Intelligence (AI)-based digital therapeutic system compared to traditional outpatient Schroth exercises for the treatment of Adolescent Idiopathic Scoliosis (AIS). The intervention utilizes a smartphone application with computer vision technology to perform remote, personalized posture analysis and generate adaptive exercise prescriptions. The study aims to determine if this "Human-in-the-Loop" AI model demonstrates superior clinical outcomes in controlling spinal curve progression and improving treatment adherence compared to standard conservative care over a 6-month period.
Description
Background: Adolescent Idiopathic Scoliosis (AIS) requires long-term conservative management to prevent curve progression. While Physiotherapeutic Scoliosis Specific Exercises (PSSE), such as the Schroth method, are the gold standard, their efficacy is often limited by accessibility barriers and suboptimal adherence. Study Design: This is a parallel-group, single-blind randomized controlled trial. A total of 300 eligible adolescents (aged 10-18, Cobb angle 10-30°, Risser sign 0-2) will be randomized in a 1:1 ratio into an Intervention Group or a Control Group. Interventions: Intervention Group (AI-DTx): Participants utilize a smartphone application to capture standardized photos every two weeks. An AI algorithm (based on MediaPipe) extracts skeletal landmarks to classify curve patterns and assign personalized exercise modules. The system features a "Check-and-Adjust" matrix to adapt exercise intensity based on metric changes. A Clinical Research Assistant (Human-in-the-Loop) verifies all prescriptions for safety before release. Control Group (Standard Care): Participants receive standard outpatient Schroth therapy, involving daily home exercises and monthly supervised clinic visits, following SOSORT guidelines. Objectives: The primary objective is to evaluate the absolute change in the major curve Cobb angle from baseline to six months. Secondary outcomes include the Angle of Trunk Rotation (ATR), trunk appearance perception (TAPS), quality of life (SRS-22r), and adherence rates. The study hypothesizes that the AI-driven intervention will demonstrate superior efficacy and adherence compared to traditional outpatient care.
Who can participate
Inclusion Criteria: 1. Diagnosis of Adolescent Idiopathic Scoliosis (AIS). 2. Age between 10 and 18 years (inclusive). 3. Cobb angle of the major curve between 10° and 30°. 4. Risser sign 0-2 (indicating skeletal immaturity). 5. Ability to operate a smartphone and follow instructions for the digital therapeutic application. 6. Patient and legal guardian provide written informed consent. Exclusion Criteria: 1. Non-idiopathic scoliosis (e.g., congenital, neuromuscular, or syndromic etiology). 2. History of prior spinal surgery or currently scheduled for surgery. 3. Contraindications to exercise therapy (e.g., cardiac or respiratory insufficiency). 4. Severe cognitive or psychiatric disorders that prevent compliance with the protocol. 5. Currently receiving other scoliosis-specific treatments (e.g., bracing) outside of the study protocol (unless stratified).
Interventions
AI-Based Digital Therapeutic System
DEVICE
Standard Outpatient Schroth Therapy
BEHAVIORAL
Locations 1
China (1)
Guangzhou Women and Children's Medical Center
Guangzhou , Guangdong
Technical details
Status
Active (not recruiting)
Phase
Not applicable
Study type
INTERVENTIONAL
Sex
Male and female
Minimum age
10 Years
Maximum age
18 Years
Healthy volunteers
No
Start date
01.02.2026
Completion date
01.01.2028
Registry ID
NCT07341633
Source
clinicaltrials.gov
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.